Kovitz Investment Group Partners, LLC, an investment management company, released its “Kovitz Core Equity Strategy” ...

Becton, Dickinson (BDX) stock gains as the company boosts fiscal 2025 earnings outlook after better than expected Q3 results.

Becton Dickinson and Co. (BDX) on Thursday reported fiscal third-quarter earnings of $574 million. On a per-share basis, the ...

Becton Dickinson & Co. closed 29.80% below its 52-week high of $251.99, which the company reached on February 3rd.

The stock's rise snapped a five-day losing streak.

Becton Dickinson beat Q3 earnings and revenue estimates, raised its FY25 EPS outlook, and saw strong growth in its medical ...

Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.

Discover how Becton Dickinson (BDX) achieved 8.5% revenue growth, expanded margins, and raised guidance in Q3 2025.

Although it sounds like an oxymoron, high-growth prospect dividend aristocrat stocks exist, although their industries may ...

Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.